A LinkedIn post from Single Quantum recaps the company’s participation in the Optica Biophotonics Congress in Fort Lauderdale, U.S. The post highlights demonstrations of the Single Quantum R12 detector as a compatible solution with PicoQuant’s MicroTime 100 system, emphasizing high detection efficiency and ultra‑low dark counts across VIS, NIR, and SWIR imaging ranges.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post also notes a talk on time-domain diffuse optics using SNSPD-based single-photon cameras and an educational “Lunch & Learn” session covering SNSPDs and careers in quantum technologies. This activity suggests Single Quantum is positioning its imaging line more prominently within biophotonics, which could support future demand for its detectors in research and medical imaging niches.
From an investor perspective, the focus on compatibility with established platforms like PicoQuant’s and on advanced spectral performance may enhance the firm’s ecosystem integration and stickiness with laboratory customers. Increased visibility at specialized conferences and engagement with early‑career professionals may also contribute to longer-term talent pipeline development and reinforce Single Quantum’s role in quantum-enabled bioimaging applications.